8 April 2023

RNZ's Kim Hill speaks to a participant in our CAR T-cell clinical trial, poet Michele Leggott.
Michele Leggott's latest book of poetry, Face to the Sky, explores her encounter with 19th-century New Zealand botanical artist Emily Cumming Harris.
But there's more to this story - Michele was battling non-Hodgkin's lymphoma while working on the book.
In early 2020, Michele received her diagnosis, just as the Covid-19 lockdowns began. Chemotherapy, radiotherapy, and a stem cell transplant in 2021 failed to cure her cancer. Finally, in early 2022, Michele was able to participate in a CAR T-cell therapy trial at the Malaghan Institute in Wellington.
"This is the future ... The Malaghan trial, the goal of that is to get publicly funded CAR T in this country so that you don't have to be on a trial to get it. If that can happen, it'll bring down hospital costs, you'll save lives."
Related articles

Kjesten Wiig: bringing life-changing treatments to life
27 February 2025

Malaghan CAR T-cell cancer therapy trial expands to Christchurch and Auckland
24 February 2025

Cancer Research Trust grant to improve CAR T-cell therapy
12 February 2025

World-renowned cancer pathologist joins the Malaghan Institute as Distinguished Research Fellow
19 December 2024

New Zealand to New York and back again: Malaghan researcher tackling liver cancer
18 November 2024

Community partnerships: Zephyr Consulting empowering emerging scientific talent
18 November 2024